Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Isolation of single-base genome-edited human iPS cells without antibiotic selection.

Miyaoka Y, Chan AH, Judge LM, Yoo J, Huang M, Nguyen TD, Lizarraga PP, So PL, Conklin BR.

Nat Methods. 2014 Mar;11(3):291-3. doi: 10.1038/nmeth.2840. Epub 2014 Feb 9.

2.

Efficient Precision Genome Editing in iPSCs via Genetic Co-targeting with Selection.

Mitzelfelt KA, McDermott-Roe C, Grzybowski MN, Marquez M, Kuo CT, Riedel M, Lai S, Choi MJ, Kolander KD, Helbling D, Dimmock DP, Battle MA, Jou CJ, Tristani-Firouzi M, Verbsky JW, Benjamin IJ, Geurts AM.

Stem Cell Reports. 2017 Mar 14;8(3):491-499. doi: 10.1016/j.stemcr.2017.01.021. Epub 2017 Feb 24.

3.

Genome editing 101: let's go digital.

Forster R, Hockemeyer D.

Nat Methods. 2014 Mar;11(3):248-9. doi: 10.1038/nmeth.2859. No abstract available.

PMID:
24577275
4.

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation.

Blair JD, Bateup HS, Hockemeyer DF.

J Vis Exp. 2016 Feb 2;(108):e53583. doi: 10.3791/53583.

5.

Efficient Gene Editing in Pluripotent Stem Cells by Bacterial Injection of Transcription Activator-Like Effector Nuclease Proteins.

Jia J, Bai F, Jin Y, Santostefano KE, Ha UH, Wu D, Wu W, Terada N, Jin S.

Stem Cells Transl Med. 2015 Aug;4(8):913-26. doi: 10.5966/sctm.2015-0030. Epub 2015 Jun 10.

6.

Precise and efficient scarless genome editing in stem cells using CORRECT.

Kwart D, Paquet D, Teo S, Tessier-Lavigne M.

Nat Protoc. 2017 Feb;12(2):329-354. doi: 10.1038/nprot.2016.171. Epub 2017 Jan 19.

PMID:
28102837
7.

Neural differentiation of induced pluripotent stem cells.

Denham M, Dottori M.

Methods Mol Biol. 2011;793:99-110. doi: 10.1007/978-1-61779-328-8_7.

PMID:
21913096
8.

Gene targeting in human pluripotent stem cells.

Liu Y, Rao M.

Methods Mol Biol. 2011;767:355-67. doi: 10.1007/978-1-61779-201-4_26.

PMID:
21822888
9.

Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editing.

Miyaoka Y, Berman JR, Cooper SB, Mayerl SJ, Chan AH, Zhang B, Karlin-Neumann GA, Conklin BR.

Sci Rep. 2016 Mar 31;6:23549. doi: 10.1038/srep23549.

10.

Genome editing in induced pluripotent stem cells.

Cheng LT, Sun LT, Tada T.

Genes Cells. 2012 Jun;17(6):431-8. doi: 10.1111/j.1365-2443.2012.01599.x. Epub 2012 Apr 4. Review.

11.

Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging.

Wang Y, Zhang WY, Hu S, Lan F, Lee AS, Huber B, Lisowski L, Liang P, Huang M, de Almeida PE, Won JH, Sun N, Robbins RC, Kay MA, Urnov FD, Wu JC.

Circ Res. 2012 Dec 7;111(12):1494-503. doi: 10.1161/CIRCRESAHA.112.274969. Epub 2012 Sep 11.

12.

[Cardiac differentiation of human iPS cells].

Kanda Y.

Nihon Yakurigaku Zasshi. 2013 Jan;141(1):32-6. Review. Japanese. No abstract available.

PMID:
23302946
13.

Factor-induced Reprogramming and Zinc Finger Nuclease-aided Gene Targeting Cause Different Genome Instability in β-Thalassemia Induced Pluripotent Stem Cells (iPSCs).

Ma N, Shan Y, Liao B, Kong G, Wang C, Huang K, Zhang H, Cai X, Chen S, Pei D, Chen N, Pan G.

J Biol Chem. 2015 May 8;290(19):12079-89. doi: 10.1074/jbc.M114.624999. Epub 2015 Mar 20.

14.

Generation of human cardiomyocytes: a differentiation protocol from feeder-free human induced pluripotent stem cells.

Di Pasquale E, Song B, Condorelli G.

J Vis Exp. 2013 Jun 28;(76). doi: 10.3791/50429.

15.

Generation and validation of PAX7 reporter lines from human iPS cells using CRISPR/Cas9 technology.

Wu J, Hunt SD, Xue H, Liu Y, Darabi R.

Stem Cell Res. 2016 Mar;16(2):220-8. doi: 10.1016/j.scr.2016.01.003. Epub 2016 Jan 13.

16.

Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System.

Li S, Xue H, Wu J, Rao MS, Kim DH, Deng W, Liu Y.

Stem Cells Dev. 2015 Dec 15;24(24):2925-42. doi: 10.1089/scd.2015.0131. Epub 2015 Nov 5.

17.

Genome modification leads to phenotype reversal in human myotonic dystrophy type 1 induced pluripotent stem cell-derived neural stem cells.

Xia G, Gao Y, Jin S, Subramony SH, Terada N, Ranum LP, Swanson MS, Ashizawa T.

Stem Cells. 2015 Jun;33(6):1829-38. doi: 10.1002/stem.1970.

18.

Converting human pluripotent stem cells to neural tissue and neurons to model neurodegeneration.

Chambers SM, Mica Y, Studer L, Tomishima MJ.

Methods Mol Biol. 2011;793:87-97. doi: 10.1007/978-1-61779-328-8_6.

PMID:
21913095
19.

Accelerating practical applications of cutting edge human iPS cell technologies.

Lindner M, Bauer G.

Nihon Yakurigaku Zasshi. 2017;149(3):115-118. doi: 10.1254/fpj.149.115. Review. Japanese. No abstract available.

PMID:
28260740
20.

Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones.

Suzuki K, Yu C, Qu J, Li M, Yao X, Yuan T, Goebl A, Tang S, Ren R, Aizawa E, Zhang F, Xu X, Soligalla RD, Chen F, Kim J, Kim NY, Liao HK, Benner C, Esteban CR, Jin Y, Liu GH, Li Y, Izpisua Belmonte JC.

Cell Stem Cell. 2014 Jul 3;15(1):31-6. doi: 10.1016/j.stem.2014.06.016.

Supplemental Content

Support Center